Phage tail-like particles kill Clostridium difficile and represent an alternative to conventional antibiotics.
Phage tail-like particles kill Clostridium difficile and represent an alternative to conventional antibiotics.
复制标题
噬菌体尾状颗粒可杀死艰难梭菌,是传统抗生素的替代品。
DOI:
10.1016/j.surg.2014.06.015
复制
发表时间:
2015
期刊:
影响因子:
3.8
通讯作者:
StewartSr,DavidB
中科院分区:
文献类型:
--
作者:
Sangster,William;Hegarty,JohnP;StewartSr,DavidB
BackgroundCurrentClostridium difficileinfection (CDI) antibiotic regimens have become increasingly ineffective at achieving cure and preventing recurrence. A recently developed alternative to conventional antibiotics are phage tail-like particles (PTLPs), which are proteins that are morphologically similar to bacteriophages and are produced byC difficile. This study examines the in vitro killing spectrum of a previously unreported PTLP isolated from a clinical isolate ofC difficile.MethodsUsing patient-derived samples from an institutional review board-approvedC difficiletissue bank, a ribotype 078C difficileisolate was anaerobically incubated on blood agar plates that were preswabbed with norfloxacin to induce the production of PTLPs. Concentrated PTLP populations were confirmed using transmission electron microscopy. Using a standard lawn spot approach, bactericidal activity was assessed as indicated by a clearing within the bacterial lawn. The PTLP genomic cluster was also fully sequenced and open reading frames were annotated according to predicted function.ResultsPTLPs were assessed using 64 patient-derivedC difficileisolates of varying ribotypes. PTLPs demonstrated complete bactericidal activity in 21 of 25 ribotype 027 isolates with partial activity in 2 of the 25. Complete bactericidal activity was not demonstrated against any other ribotype or non-difficilebacteria, suggesting a species and ribotype specificity. Functional genes, which may be necessary for killing, were identified within the PTLP genetic locus.ConclusionPTLPs demonstrate capability in eradicatingC difficilein vitro, and with further development, may represent an organism-specific, microbiome-sparing therapy for CDI.
登录
查看更多内容
影响因子:
4.4
作者:
J. Šmarda;O. Benada
通讯作者:
O. Benada
影响因子:
3.7
作者:
Nale JY;Shan J;Hickenbotham PT;Fawley WN;Wilcox MH;Clokie MR
通讯作者:
Clokie MR
影响因子:
3.2
作者:
Gebhart, Dana;Williams, Steven R.;Scholl, Dean
通讯作者:
Scholl, Dean
影响因子:
4.4
作者:
E. Strauch;H. Kaspar;C. Schaudinn;P. Dersch;K. Madela;C. Gewinner;S. Hertwig;J. Wecke;B. Appel
通讯作者:
B. Appel
影响因子:
4.4
作者:
Fortier, Louis-Charles;Moineau, Sylvain
通讯作者:
Moineau, Sylvain